Predicted protein targets (top 19)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 6/20 | 0.64 |
| ▸ | CA2 | P00918 | 6/20 | 0.64 |
| ▸ | PARP10 | Q53GL7 | 2/20 | 0.64 |
| ▸ | PARP1 | P09874 | 1/20 | 0.64 |
| ▸ | PARP2 | Q9UGN5 | 1/20 | 0.64 |
| ▸ | PARP4 | Q9UKK3 | 1/20 | 0.64 |
| ▸ | MAPT | P10636 | 1/20 | 0.58 |
| ▸ | CES2 | O00748 | 2/20 | 0.57 |
| ▸ | CES1 | P23141 | 2/20 | 0.57 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.53 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.53 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.53 |
| ▸ | PLK1 | P53350 | 1/20 | 0.50 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.49 |
| ▸ | RAB9A | P51151 | 1/20 | 0.49 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.49 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.49 |
| ▸ | GAA | P10253 | 1/20 | 0.49 |
| ▸ | GSK3B | P49841 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29926783 | 0.87 | CA1 (0.48) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL5378414 | 0.83 | MAPT (0.59) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL1450228 | 0.82 | PARP10 (0.39) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL18982976 | 0.82 | CES2 (0.72) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL28597822 | 0.82 | MAPT (0.66) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL562943 | 0.82 | CA1 (0.63) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL11351909 | 0.80 | PDE4A (0.47) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL28547220 | 0.80 | MAPT (0.58) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL4910445 | 0.80 | CA1 (0.59) | CA1CA2PARP10PARP1PARP2 | |
| SCHEMBL2224707 | 0.79 | PARP10 (0.68) | PARP10MAPTMAPK1RAB9AHSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 22 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| JP-4828407-B2 | — | — | 2011-11-30 | — | — | JP | claimed |
| WO-2008062424-A2 | SUBSTITUTED 4,5-DIHYDRO-1H-PYRAZOLE DERIVATIVES AS CANNABINOID MODULATORS | CADILA HEALTHCARE LIMITED (IN) | 2008-05-29 | — | — | WO | claimed |
| CN-1234785-C | Liquid ink containing surface treatment coloring agent particle and productive method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-01-04 | — | — | CN | claimed |
| EP-1594869-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | Targacept, Inc. (US) | 2005-11-16 | — | — | EP | claimed |
| WO-2004076449-A2 | 3-SUBSTITUTED-2(ARYLALKYL)-1-AZABICYCLOALKANES AND METHODS OF USE THEREOF | TARGACEPT, INC. (US) | 2004-09-10 | — | — | WO | claimed |
| CN-1358807-A | Liquid ink containing surface treatment coloring agent particle and productive method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2002-07-17 | — | — | CN | claimed |
| CN-87101979-A | diphenylmethane derivatives and pharmaceutical use | — | 1987-10-28 | — | — | CN | claimed |
| WO-2026047630-A1 | HETEROCYCLIC COMPOUNDS AS EGFR INHIBITORS | HETERO LABS LIMITED (IN) | 2026-03-05 | — | — | WO | disclosed |
| US-20250057850-A1 | ERBB/BTK INHIBITORS | DIZAL JIANGSU PHARMACEUTICAL CO LTD (CN) | 2025-02-20 | — | — | US | disclosed |
| CN-111747950-B | Pyrimidine derivatives for the treatment of cancer | 深圳福沃药业有限公司 | 2024-01-23 | — | — | CN | disclosed |
| CN-111875585-B | Kinase inhibitors | 上海艾力斯医药科技股份有限公司 | 2023-06-23 | — | — | CN | disclosed |
| CN-111686110-B | Compounds and compositions for modulating EGFR mutant kinase activity | 株式会社柳韩洋行 | 2023-06-16 | — | — | CN | disclosed |
| CN-115322131-A | Synthesis method of beta-fluoroindole acrylamide compound | 温州大学 | 2022-11-11 | — | — | CN | disclosed |
| CN-101138036-A | Improved disks for data storage | MEMPILE INC (US) | 2008-03-05 | — | — | CN | disclosed |
| CN-1234785-C | Liquid ink containing surface treatment coloring agent particle and productive method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2006-01-04 | — | — | CN | disclosed |
| CN-1358807-A | Liquid ink containing surface treatment coloring agent particle and productive method thereof | SAMSUNG ELECTRONICS CO LTD (KR) | 2002-07-17 | — | — | CN | disclosed |
| CN-1014889-B | Method for producing stilbene derivative | EISAI CO LTD (JP) | 1991-11-27 | — | — | CN | disclosed |
| CN-87101979-A | diphenylmethane derivatives and pharmaceutical use | — | 1987-10-28 | — | — | CN | disclosed |
| EP-0001997-B1 | ELECTRON BEAM-CURABLE PHOTORESIST LACQUERS | BAYER AG (DE) | 1981-02-11 | — | — | EP | disclosed |
| EP-0001997-A1 | Electron beam-curable photoresist lacquers | BAYER AG (DE) | 1979-05-30 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250057850-A1 | ERBB/BTK INHIBITORS | ERBB2, BTK, ERBB3 | CA1 4026/4885CA2 1603/4885PARP10 1837/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.